This inventor holds 1 USPTO granted patent. Top assignee: Muscagen Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Luis Garcia Sevillano
Introduction
Luis Garcia Sevillano is a notable inventor based in Toro, Spain. He has made significant contributions to the field of pharmacology, particularly through his work on adenosine analogue-type A3 receptor agonists. His innovative approach has led to the development of a unique patent that showcases his expertise and creativity.
Latest Patents
Luis Garcia Sevillano holds a patent for adenosine analogue-type A3 receptor agonists. This patent includes a specific formula wherein D is N or CH, E is O, and X is a group of the formula —CRR-CYCLE. This invention highlights his ability to create novel compounds that may have important therapeutic applications.
Career Highlights
Throughout his career, Luis has demonstrated a strong commitment to research and innovation. He is currently associated with Muscagen Limited, where he continues to explore new avenues in drug development. His work has not only advanced scientific knowledge but also has the potential to impact patient care positively.
Collaborations
Luis has collaborated with esteemed colleagues such as Christopher McGuigan and Robin Havard Davies. These partnerships have enriched his research and contributed to the success of his projects.
Conclusion
Luis Garcia Sevillano is a distinguished inventor whose work in pharmacology has led to valuable innovations. His patent on adenosine analogue-type A3 receptor agonists exemplifies his dedication to advancing medical science. His contributions are likely to have a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile